AKTIVITAS ANTI-Mycobacterium tuberculosis KOMBINASI (-)- EPIGALLOCATECHIN-GALLATE (EGCG) DAN OBAT ANTITUBERKULOSIS LINI PERTAMA

ANGGITA MIRZAUTIKA, 051314153027 (2016) AKTIVITAS ANTI-Mycobacterium tuberculosis KOMBINASI (-)- EPIGALLOCATECHIN-GALLATE (EGCG) DAN OBAT ANTITUBERKULOSIS LINI PERTAMA. Thesis thesis, UNIVERSITAS AIRLANGGA.

[img]
Preview
Text (HALAMAN DEPAN)
HALAMAN DEPAN.pdf

Download (2MB) | Preview
[img] Text (BAB I)
15. Bab 1 Pendahuluan.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 2)
16. Bab 2 Tinjauan Pustaka.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 3)
17. Bab 3 Kerangka Konseptual dan Hipotesis Penelitian.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 4)
18. Bab 4 Materi dan Metode Penelitian.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 5)
19. Bab 5 Hasil Penelitian.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 6)
20. Bab 6 Pembahasan.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (BAB 7)
21. Bab 7 Kesimpulan dan Saran.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (DAFTAR PUSTAKA)
22. Daftar Pustaka.pdf
Restricted to Registered users only

Download (764kB) | Request a copy
[img] Text (LAMPIRAN)
23. Lampiran.pdf
Restricted to Registered users only

Download (5MB) | Request a copy
Official URL: http://lib.unair.ac.id

Abstract

Tuberculosis (TB) is a global health issue, and moreover there are increasing cases of multidrug-resistant tuberculosis (MDR-TB) in the world. So the researchers have been trying to find new tuberculosis therapy that is more effective. In this study, the therapy that has been chosen is (-)-epigallocatechingallate (EGCG), from tea leaves (Camellia sinensis), used in combination with each of the first line antituberculosis drugs. The aim of this study is to find whether EGCG can increase the activity of the first line antituberculosis drugs against M. tuberculosis. If EGCG can increase their activity, it can be new alternative tuberculosis treatment that is more effective. The minimum inhibitory concentration (MIC) of each antituberculosis drug was determined by broth dilution method using Middlebrook 7H9 medium, the MIC result was 5 ppm, 0.5 ppm, 50 ppm and 5 ppm for rifampicin, isoniazid, pyrazinamide and ethambutol, respectively. Then the MIC of EGCG combination with each antituberculosis drug was also determined by the same method. The MIC after combination was 0.5 ppm, 0.25 ppm, 20 ppm and 2 ppm for rifampicin, isoniazid, pyrazinamide and ethambutol, respectively. The result shows that the MIC of each first line antituberculosis drug was decreased due to the combination of EGCG. It shows that EGCG gives synergism effect when combined with those drugs, so it can be concluded that EGCG can be used as a complement of antituberculosis drugs for more effective tuberculosis therapy.

Item Type: Thesis (Thesis)
Additional Information: KKB KK-2 TF.01/16 Mir a
Uncontrolled Keywords: EGCG, First-line antituberculosis drugs, Anti-Mycobacterium tuberculosis, synergism
Subjects: R Medicine > RS Pharmacy and materia medica > RS1-441 Pharmacy and materia medica
Divisions: 05. Fakultas Farmasi
Creators:
CreatorsEmail
ANGGITA MIRZAUTIKA, 051314153027UNSPECIFIED
Contributors:
ContributionNameEmail
ContributorIsnaeni, Dr., MS., Apt.UNSPECIFIED
ContributorDjoko Agus Purwanto, Prof. Dr. , M.Si., Apt.UNSPECIFIED
Depositing User: Guruh Haris Raputra
Date Deposited: 20 Apr 2016 05:24
Last Modified: 20 Apr 2016 05:34
URI: http://repository.unair.ac.id/id/eprint/29571
Sosial Share:

Actions (login required)

View Item View Item